Table 4.
One‐Year Events of All Study Patients
| fQRS (–) | fQRS (+) | ||
|---|---|---|---|
| variable | (n = 323) | (n = 91) | P Value |
| All‐cause mortality, n (%) | 8 (2.5) | 21 (23.1) | <0.001 |
| Cardiovascular mortality, n (%) | 7 (2.2) | 22 (24.2) | <0.001 |
| Noncardiac mortality, n (%) | 1 (0.3) | 1 (1.1) | 0.34 |
| Fatal reinfarction, n (%) | 4 (1.2) | 9 (9.9) | <0.001 |
| Nonfatal reinfarction, n (%) | 17 (5.3) | 10 (11) | 0.05 |
| Target‐vessel revascularization, n (%) | 30(9.3) | 16(17.6) | 0.03 |
| Stroke, n (%) | 5 (1.5) | 2 (2.2) | 0.67 |
| Advanced heart failure, n (%) | 40 (12.4) | 30 (33) | <0.001 |
| MACE, n (%) | 39 (12.1) | 37 (40.7) | <0.001 |
MACE = major adverse cardiac events (cardiovascular mortality, reinfarction, target‐vessel revascularization).